Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Optimal Treatment of Marfan Syndrome

NCT05944614 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT05944614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05944614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Optimal Treatment of Marfan Syndrome
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Observational
Overall status
Completed
Start date
February 23, 2023
Completion date
April 16, 2025
Enrollment
148 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

marfan syndrome